Modeling tumor-associated edema in gliomas during anti-angiogenic therapy and its impact on imageable tumor

Andrea Hawkins-Daarud, Russell C. Rockne, Alexander R.A. Anderson, Kristin R. Swanson

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


Glioblastoma, the most aggressive form of primary brain tumor, is predominantly assessed with gadolinium-enhanced T1-weighted (T1Gd) and T2-weighted magnetic resonance imaging (MRI). Pixel intensity enhancement on the T1Gd image is understood to correspond to the gadolinium contrast agent leaking from the tumor-induced neovasculature, while hyperintensity on the T2/FLAIR images corresponds with edema and infiltrated tumor cells. None of these modalities directly show tumor cells; rather, they capture abnormalities in the microenvironment caused by the presence of tumor cells. Thus, assessing disease response after treatments impacting the microenvironment remains challenging through the obscuring lens of MR imaging. Anti-angiogenic therapies have been used in the treatment of gliomas with spurious results ranging from no apparent response to significant imaging improvement with the potential for extremely diffuse patterns of tumor recurrence on imaging and autopsy. Anti-angiogenic treatment normalizes the vasculature, effectively decreasing vessel permeability and thus reducing tumor-induced edema, drastically altering T2-weighted MRI. We extend a previously developed mathematical model of glioma growth to explicitly incorporate edema formation allowing us to directly characterize and potentially predict the effects of anti-angiogenics on imageable tumor growth. A comparison of simulated glioma growth and imaging enhancement with and without bevacizumab supports the current understanding that anti-angiogenic treatment can serve as a surrogate for steroids and the clinically driven hypothesis that anti-angiogenic treatment may not have any significant effect on the growth dynamics of the overall tumor cell populations. However, the simulations do illustrate a potentially large impact on the level of edematous extracellular fluid, and thus on what would be imageable on T2/FLAIR MR. Additionally, by evaluating virtual tumors with varying growth kinetics, we see tumors with lower proliferation rates will have the most reduction in swelling from such treatments.

Original languageEnglish (US)
Article numberArticle 00066
JournalFrontiers in Oncology
Volume3 APR
StatePublished - 2013


  • Anti-angiogenic therapy
  • Edema
  • Glioma
  • Mathematical model

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Modeling tumor-associated edema in gliomas during anti-angiogenic therapy and its impact on imageable tumor'. Together they form a unique fingerprint.

Cite this